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Phosphoinositides are minor amphipathic constituents of biological membranes. The 
most common phosphoinositide in the inner leaflet of the plasma membrane is phosphoinositol 
4,5-bisphosphate (PI(4,5)P2), which forms ca. 1% of the total phospholipid pool of the 
membrane. PI(4,5)P2 is not only a precursor of well-known second messengers such as IP3 and 
DAG, but also directly regulates several ion channels, including TRP channels1. In recent years, 
many TRP channels were found to be positively regulated by PI(4,5)P2, although in some cases 
inhibitory effects were reported. In our recent work2 and in an independent study by the group 
of prof. Tibor Rohács in the Journal of General Physiology3, we reported that TRPM3 is also 
tightly regulated by phosphoinositides. However, its specificity is toward PI(4,5)P2 is much 
lower than what was found for other TRP channels, including other PI(4,5)P2-sensitive members 
of the TRPM subfamily. 
Until a few years ago, TRPM3 was one of the less characterized members of the TRP 
superfamily, considered as a quite enigmatic channel having several transcript variants with 
unclear activation mechanism and functions. More recently, the channel entered the spotlight 
when it was identified as a steroid activated, heat sensitive ion channel that plays important 
roles in thermosensation and nociception in primary sensory neurons as well as in regulating 
insulin secretion in beta cells4, 5. However, little is known about the cellular regulation of the 
channel. 
In the highlighted papers, we provide the first information on how TRPM3 may be 
regulated at the cellular level by various signaling pathways, which may shape its function in 
sensory neurons or beta cells. We demonstrate that enzymatic removal of PI(4,5)P2 decreased 
the activity of TRPM3 in whole-cell patch-clamp measurements and in intact cells, whereas 
exogenous PI(4,5)P2 applied to the intracellular surface of the plasma membrane restored 
TRPM3 currents in inside-out patches. This finding links TRPM3 activity to metabotropic 
receptors that signal via PLC, such as histamine or bradykinin receptors, which are implicated in 
nociception and inflammation. However, the only partial effectiveness, even at high 
concentrations, of exogenous short chain PI(4,5)P2 isoforms (compared with e.g. TRPM4
1) and 
the moderate effect of enzymatic PI(4,5)P2 degradation (compared with e.g. TRPM8
1) suggested 
that other factors beyond PI(4,5)P2 influence channel activity. For instance, we found that the 
length of the acyl chain in PIPs has a significant effect on the PI(4,5)P2 mediated current 
recovery, probably influencing the membrane integration of the exogenous PI(4,5)P2. More 
interestingly, we observed that PI(3,4,5)P3 is the most effective PIP in activating TRPM3, with a 
potency that far exceeds that of PI(4,5)P2. This low PIP selectivity, and in particular the high 
PI(3,4,5)P3 preference of TRPM3 is unique among TRP channels. Whether PI(3,4,5)P3 acts as a 
positive cofactor under physiological circumstances is unclear, since PI(3,4,5)P3 levels in the 
membrane of resting cells are believed to be too low to have a meaningful effect on channel 
activity. It will be of great interest to investigate whether signaling events that lead to increased 
membrane PI(3,4,5)P3 levels, in particular receptors that cause activation of phosphoinositol 3-
kinase (PI3K), regulate the activity of TRPM3 in vitro and in vivo.  
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Another unresolved question is the location of the binding site(s) for the PIPs on TRPM3. 
In the TRPM subfamily we can find examples where the binding sites are located in the C 
terminal TRP box, such as TRPM81 or TRPM66. In contrast, putative C-terminal PH-like domains 
were identified as PI(4,5)P2 binding sites in TRPM4
1. Regarding TRPM3, the only data were 
presented in the pages of “Channel” in the form of an Addendum paper, in which Holendova 
and colleagues showed that protein constructs containing N-terminal fragments of the human 
TRPM3, which bind Ca2+-calmodulin and S100A1, can bind to PI(4,5)P2 as well
7. This result 
argues for the existence of a PI(4,5)P2 binding site outside of the C-terminal TRP box, but its 
nature and exact location remains unknown. 
In our recent work, wild type TRPM3 was found to exhibit an alternative pore analogous 
to the gating pore/omega pore in mutant voltage-gated channels, with potential importance for 
its sensory functions8. To our knowledge, there are no data concerning PIP regulation of such 
gating pores in any ion channels. An interesting outstanding question is whether the physically 
separate alternative pore in TRPM3 is regulated in a similar manner to the main central pore.  
Overall, these studies allow us to include TRPM3 in the list of channels and transporters 
regulated by PIPs. Our findings raise several exciting questions, both on the molecular (“What 
determines PIP selectivity in TRP channels?”) and (patho)physiological level(“Do PIPs regulate 
TRPM3 to tune sensory sensitivity or insulin secretion?”).  
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Figure 1. Phosphoinositols regulate TRPM3. ATP and exogenous PIPs applied to the 
cytoplasmic surface restore the TRPM3 current after desensitization in inside-out membrane 
patches. ATP was found to restore the PIP2 level in the plasma membrane. The efficacy of 
exogenous PIPs depends on the negatively charged polar head group and the length of the acyl 
chains, as well. For more details see the text. Abbreviations: PIKs – phosphatidylinositol kinases, 
PIP – phosphatidylinositol (mono)phosphate, PIP2 – phosphatidylinositol bisphosphate, diC8 
PIP2 – dioctanoyl phosphatidylinositol bisphosphate, diC8 PIP3 – dioctanoyl phosphatidylinositol 
trisphosphate, diC16 PIP2 – dipalmitoyl phosphatidylinositol bisphosphate, PregS – pregnenlone 
sulfate. 
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